Given that the skeletal muscle function is compromised in ALS, the implication that HDAC4 could be protective in ALS skeletal muscle has questioned the use of broad-range HDAC inhibitors as a strategy for ALS treatment [82]. Here, HDAC4 is linked to amyotrophic lateral sclerosis.